The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, released a statement today in response to The New York Times article on the negative influence that pharmacy benefit managers (PBMs) have on the rising cost of healthcare.
“The New York Times investigation into the opaque, anticompetitive practices of pharmacy benefit managers (PBMs) underscores the urgent need for PBM reform. It’s past time to rein in PBMs’ profit-driven practices that are harming patients, providers and taxpayers,” said Alan Rosenbloom, President and CEO of SCPC. “This is a heightened issue for the long-term care pharmacy community, as PBM market consolidation is worse among long-term care pharmacies and because of our patients’ heavy reliance on Medicare Part D. The big three PBMs account for more than 80 percent of the prescription drug market. Without increased transparency and accountability, mega health-insurers and their PBM counterparts will continue to vertically integrate, putting long-term care pharmacies, the patients we serve, and our overall healthcare system at risk. Congress must act quickly to hold PBMs accountable and pass meaningful reform that results in true cost savings and increased access to care.”
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.